Lewis, K. H., Arterburn, D. E., Zhang, F., Callaway, K., Wallace, J., Fernandez, A., … Wharam, J. F. (2022). Response to "Why Gastric Bypass Might Not be a Good Choice for Type-2 Diabetes Treatment". Ann Surg, 276(2), e138–e139. https://doi.org/10.1097/SLA.0000000000005269

Lewis, Kristina H., David E. Arterburn, Fang Zhang, Katherine Callaway, Jamie Wallace, Adolfo Fernandez, Dennis Ross-Degnan, and James F. Wharam. “Response to "Why Gastric Bypass Might Not be a Good Choice for Type-2 Diabetes Treatment".” Ann Surg 276, no. 2 (August 1, 2022): e138–39. https://doi.org/10.1097/SLA.0000000000005269.

Lewis KH, Arterburn DE, Zhang F, Callaway K, Wallace J, Fernandez A, et al. Response to "Why Gastric Bypass Might Not be a Good Choice for Type-2 Diabetes Treatment". Ann Surg. 2022 Aug 1;276(2):e138–9.

Lewis, Kristina H., et al. “Response to "Why Gastric Bypass Might Not be a Good Choice for Type-2 Diabetes Treatment".” Ann Surg, vol. 276, no. 2, Aug. 2022, pp. e138–39. Pubmed, doi:10.1097/SLA.0000000000005269.

Lewis KH, Arterburn DE, Zhang F, Callaway K, Wallace J, Fernandez A, Ross-Degnan D, Wharam JF. Response to "Why Gastric Bypass Might Not be a Good Choice for Type-2 Diabetes Treatment". Ann Surg. 2022 Aug 1;276(2):e138–e139.